Assessment of effectiveness of individualized Homoeopathic medicine on Generalized anxiety disorder and quality of life -A quasi experimental study.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 37
- 试验地点
- 1
- 主要终点
- Reduction in score of the Hamilton Anxiety Rating Scale and WHOQOL BREF at the end of 6 months of follow up
研究概览
简要总结
“Generalized anxiety disorder (GAD) is defined as excessive anxiety and worry about several events or activities for most days during at least a 6-month period. The worry is difficult to control and is associated with somatic symptoms, such as muscle tension, irritability, difficulty in sleeping, and restlessness”.GAD is one of the important subtypes of anxiety disorders affecting a person’s ability to live well, work well and have a productive life.
The specific cause of GAD is idiopathic. Probable causes may be of biological (Neurochemical imbalance, familial heredity), psychological (low self-esteem, poor coping abilities) or of social (Chronic stress, poverty, trauma, lack of support and urban living)origins. GAD affects not only the psychological sphere but also the somatic component of the person’s life. The overall quality of life is significantly affected by reduced work quality and a lack of enjoyment in life.
Homoeopathy, with its holistic and individualized approach, focuses on treating the person as a whole by addressing their susceptibility to illness. It offers a potential avenue for safe, gentle, and long-lasting relief. Homoeopathic remedies are prescribed considering the person as a whole and not their individual parts. Thus, showing immense scope in its treatment, which is an understudied area.
So, here is a sincere effort to assess the effectiveness of individualized Homoeopathic medicines in the treatment of GAD.
RESEARCH HYPOTHESIS: Individualized Homoeopathic medicines may be effective in the treatment of Generalized Anxiety Disorder.
NULL HYPOTHESIS: Individualized Homoeopathic medicines may not be effective in the treatment of Generalized Anxiety Disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Subjects who have given consent for the study
- •Subjects satisfying the DSM 5 Diagnostic Criteria for Generalized Anxiety Disorder
- •All adults in the age group 20 to 60 irrespective of socioeconomic status gender and ethnic group
- •Subjects with mild and moderate anxiety according to the Hamilton Anxiety Rating Scale.
排除标准
- •Subjects with severe anxiety and no anxiety according Hamilton Anxiety Rating Scale
- •Subjects who are suffering from panic disorder phobias OCD PTSD and major depressive disorder 3.
结局指标
主要结局
Reduction in score of the Hamilton Anxiety Rating Scale and WHOQOL BREF at the end of 6 months of follow up
时间窗: Reduction in the clinical score of HAM A and WHOQOL BREF at the end of 6 month of follow up
次要结局
- Reduction in the clinical symptoms of generalised anxiety disorder and improvement in quality of life(All subjects will be followed up every 15 days and as per the need of each case for a period of 6 months)
研究者
Dr Pragati Ningappa Muddikol
Dr B D Jatti Homoeopathic medical college hospital and P G research centre Dharwad Karnataka